Get the Weekly Intelligence Brief — top committee picks every Sunday.
BFLY · NYSE · STOCK

Butterfly Network, Inc.

Healthcare Updated August 11, 2026
$9.36
52W $1.34 – $10.05
67/100
$2.50B
-32.4
2.08
AI Committee Verdict
Buy
67/100
Conviction: Moderate · 67% agreement · 6 analysts
Moderate

Is BFLY Bullish or Bearish?

Bullish. Innellis AI committee rates Butterfly Network, Inc. (BFLY) Buy with a composite score of 67/100 , based on 6 analysts with 67% agreement. Last updated August 11, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +8.08 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -11.92 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The primary driver is revenue growing 28.1% yoy -- genuine top-line momentum. The main limiting factor is roe of only -38.4% -- cheap may mean cheap for a reason. The committee is constructive but not yet at full conviction.

Bull & Bear Case

Bull Case
  • Revenue growing 28.1% YoY -- genuine top-line momentum — Growth
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
  • Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
  • Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock — Risk
Bear Case
  • ROE of only -38.4% -- cheap may mean cheap for a reason — Value
  • Bollinger bandwidth of 52.6% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 11, 2026
Overall Committee Score
67/100
Agreement
67%
Analysts
6
Conviction
Moderate
Sector Rank
Top 9%
of 192 Healthcare peers
Value Analyst neutral
52 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− ROE of only -38.4% -- cheap may mean cheap for a reason
Growth Analyst bullish
85 / 100 · Low confidence
Strong, accelerating growth with consistent execution
+ Revenue growing 28.1% YoY -- genuine top-line momentum
Technical Analyst bullish
69 / 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
Risk Analyst neutral
58 / 100 · Moderate confidence
Moderate risk -- no single red flag, but nothing that clearly de-risks the position either
+ Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock
− Bollinger bandwidth of 52.6% signals elevated volatility
Macro Analyst bullish
78 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst bullish
61 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager neutral
55 / 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Open Full Terminal →

Technical Analysis

RSI (14)
66.4
Neutral
MACD Histogram
0.200
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Support
$3.77
Resistance
$9.68
Bollinger %B
0.93
Inside Bands
Price vs Moving Averages
EMA 9
$8.61 Above
EMA 21
$8.00 Above
EMA 50
$7.16 Above
EMA 200
$5.07 Above

Fundamental Analysis

Valuation
33
Profitability
19
Financial Health
100
Cash Flow
15
Valuation
P/E Ratio -32.4×
P/B Ratio 12.97×
PEG Ratio 4.58
Dividend Yield 0.00%
52W High $10.05
52W Low $1.34
Quality & Growth
ROE -3932.3%
ROA -2598.8%
Gross Margin 5107.8%
Operating Margin -7277.2%
Revenue Growth YoY
Debt / Equity 0.10
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of -32.4 (inexpensive relative to a 15-40x range); Price-to-book of 13.0x; PEG ratio of 4.6 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -39.3%; Return on assets of -26.0%; Net margin of -68.9%; Gross margin of 51.1%; Current ratio of 4.06 (healthy short-term liquidity); Debt-to-equity of 0.10; Free cash flow per share is negative (-0.14); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full BFLY Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore BFLY Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime